Javascript must be enabled to continue!
Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage
View through CrossRef
AbstractThe shortage of organs for transplantation emphasizes the urgent need for alternative solutions. Xenotransplantation has emerged as a promising option due to the greater availability of donor organs. However, significant hurdles such as hyperacute rejection and organ ischemia–reperfusion injury pose major challenges, largely orchestrated by the complement system, and activated immune responses. The complement system, a pivotal component of innate immunity, acts as a natural barrier for xenotransplantation. To address the challenges of immune rejection, gene-edited pigs have become a focal point, aiming to shield donor organs from human immune responses and enhance the overall success of xenotransplantation. This comprehensive review aims to illuminate strategies for regulating complement networks to optimize the efficacy of gene-edited pig xenotransplantation. We begin by exploring the impact of the complement system on the effectiveness of xenotransplantation. Subsequently, we delve into the evaluation of key complement regulators specific to gene-edited pigs. To further understand the status of xenotransplantation, we discuss preclinical studies that utilize gene-edited pigs as a viable source of organs. These investigations provide valuable insights into the feasibility and potential success of xenotransplantation, offering a bridge between scientific advancements and clinical application.
Springer Science and Business Media LLC
Title: Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage
Description:
AbstractThe shortage of organs for transplantation emphasizes the urgent need for alternative solutions.
Xenotransplantation has emerged as a promising option due to the greater availability of donor organs.
However, significant hurdles such as hyperacute rejection and organ ischemia–reperfusion injury pose major challenges, largely orchestrated by the complement system, and activated immune responses.
The complement system, a pivotal component of innate immunity, acts as a natural barrier for xenotransplantation.
To address the challenges of immune rejection, gene-edited pigs have become a focal point, aiming to shield donor organs from human immune responses and enhance the overall success of xenotransplantation.
This comprehensive review aims to illuminate strategies for regulating complement networks to optimize the efficacy of gene-edited pig xenotransplantation.
We begin by exploring the impact of the complement system on the effectiveness of xenotransplantation.
Subsequently, we delve into the evaluation of key complement regulators specific to gene-edited pigs.
To further understand the status of xenotransplantation, we discuss preclinical studies that utilize gene-edited pigs as a viable source of organs.
These investigations provide valuable insights into the feasibility and potential success of xenotransplantation, offering a bridge between scientific advancements and clinical application.
Related Results
Requirements of informed‐consent to xenotransplantation: a qualitative interview study
Requirements of informed‐consent to xenotransplantation: a qualitative interview study
BackgroundThe aim is to establish xenotransplantation as a possible alternative to allotransplantation. The clinical application requires that patients give their informed consent ...
Xenotransplantation public perceptions: rather cells than organs
Xenotransplantation public perceptions: rather cells than organs
Omnell Persson M, Persson NH, Ranstam J, Hermerén G. Xenotransplantation public perceptions, rather cells than organs. Xenotransplantation 2003; 10: 72–79. © Blackwell Munksgaard, ...
Clinical Islet Xenotransplantation: Development of Isolation Protocol, Anti-Rejection Strategies, and Clinical Outcomes
Clinical Islet Xenotransplantation: Development of Isolation Protocol, Anti-Rejection Strategies, and Clinical Outcomes
Allogeneic islet transplantation has become a standard therapy for unstable type 1 diabetes. However, considering the large number of type 1 diabetic patients, the shortage of dono...
Percutaneous Coronary Intervention Outcomes in Solid Organ Transplant Candidates
Percutaneous Coronary Intervention Outcomes in Solid Organ Transplant Candidates
Background: As part of the pre-transplant assessment, patients with end-stage renal, liver, pancreas, or lung disease who wish to attain transplant eligibility must undergo evaluat...
How should cardiac xenotransplantation be initiated in Japan?
How should cardiac xenotransplantation be initiated in Japan?
AbstractThe world's first clinical cardiac xenotransplantation, using a genetically engineered pig heart with 10 gene modifications, prolonged the life of a 57-year-old man with no...
Current Aspects of Xenotransplantation in Human
Current Aspects of Xenotransplantation in Human
Xenotransplantation is an approach which will be able to support the increasing demand of organ donation since the organ does not need to come from humans. Up till now, xenotranspl...
Simultaneous Heart-Kidney Transplant—Does Hospital Experience With Heart Transplant or Kidney Transplant Have a Greater Impact on Patient Outcomes?
Simultaneous Heart-Kidney Transplant—Does Hospital Experience With Heart Transplant or Kidney Transplant Have a Greater Impact on Patient Outcomes?
High institutional transplant volume is associated with improved outcomes in isolated heart and kidney transplant. The aim of this study was to assess trends and outcomes of simult...
Production of Four‐Gene (GTKO/hCD55/hTBM/hCD39)‐Edited Donor Pigs and Kidney Xenotransplantation
Production of Four‐Gene (GTKO/hCD55/hTBM/hCD39)‐Edited Donor Pigs and Kidney Xenotransplantation
ABSTRACTBackgroundThe number of multigene‐modified donor pigs for xenotransplantation is increasing with the advent of gene‐editing technologies. However, it remains unclear which ...


